7 Oct 2026 · 34 min
S16 E07 Expanding Market Access and Innovative Medicines
Country General Manager of Alnylam Pharmaceuticals’ Colleen Coxson discusses compliance and self-regulation, the potential for siRNA on Alzheimer’s, and the future of drug development. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe






